Randomized, Controlled Trial of Cyclophosphamide, Methotrexate, and Fluorouracil Versus Cyclophosphamide, Doxorubicin, and Fluorouracil With and Without Tamoxifen for High-Risk, Node-Negative Breast Cancer: Treatment Results of Intergroup Protocol INT-0102

HUTCHINS, Laura F ; GREEN, Stephanie J ; RAVDIN, Peter M ; LEW, Danika ; MARTINO, Silvana ; ABELOFF, Martin ; LYSS, Alan P ; ALLRED, Craig ; RIVKIN, Saul E ; OSBORNE, C. Kent

Journal of clinical oncology, 2005-11, Vol.23 (33), p.8313-8321 [Periódico revisado por pares]

Baltimore, MD: American Society of Clinical Oncology

Sem texto completo